Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., Watanabe, E., Takagi, T., Akiyoshi, M., ohtsubo, T., Kihara, S., Yamashita, S., Makishima, M., Funahashi, T., Yamanaka, S., Hiramatsu, R., Matsuzawa, Y. and Shimomura, I. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426-430.

Balkau, B., Vierron, E., Vernay, M., Born, C., Arondel, D., Petrella, A. and Ducimetiere, P. (2006) The impact of 3-year changes in lifestyle habits on metabolic syndrome parameters: the DESIR Study. European Journal of Cardiovascular Prevention and Rehabilitation 13, 334-340.

Berndt, J., Kloting, N., Kralisch, S., Kovacs, P., Fasshauer, M., Schon, M.R., Stumvoll, M. and Bluher, M. (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54, 2911-2916.

Burstein, M. and Sammaille, G. (1960) On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins. Clinica Chimica Acta 5, 609-610.

Case, C.C., Jones, P.H., Nelson, K., O'Brian Smith, E. and Ballantyne, C.M. (2002) Impact of weight loss on the metabolic syndrome. Diabetes Obesity and Metabolism 4, 407-414.

Cheriyath, P., Duan, Y., Qian, Z., Nambiar, L. and Liao, D. (2010) Obesity, physical activity and the development of metabolic syndrome: the Atherosclerosis Risk in Communities study. European Journal of Cardiovascular Prevention and Rehabilitation 17(3), 309-313.

Choi, K.M., Kin, J.H., Cho, J.H., Baik, S.H., Park, H.S. and Kim, S.M. (2007) Effect of exercise training on plasma visfatin and eotaxin levels. European Journal of Endocrinology 157(4), 437-442.

Eckel, R.H., Scott, M.G. and Zimmet, P. (2005) The metabolic syndrome. Lancet 3365, 1415-428.

Ford, E.S. (2005) Risks for all-causes mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28, 1769-1785.

Gale, E.A. (2008) Should we dump the metabolic syndrome? British Medical Journal. 336(7645), 640.

Gupta, A. and Gupta, V. (2010) Metabolic syndrome: What are the risks for humans? BioScience Trends 4(5), 202-212.

Jensky-Squires, N.E., Dieli-Conwright, C.M., Rossuello, A., Erceg, D.N., McCauley, S. and Schroeder, E.T. (2008) Validity and reliability of body composition analysers in children and adults. British Journal of Nutrition 100(4), 859-865.

National Cholesterol Education Program (NCEP). (2002) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3121.

Pagano, C., Pilon, C., Olivieri, M., Mason, P., Fabris, R., Serra, R., Milan, G., Rossato, M., Federspil, G. and Vetter, R. (2006) Reduce plasma visfatin/pre B-cell colony enhancing factor in obesity is not related to insulin resistance in humans. Journal of Clinical Endocrinology and Metabolism 91(8), 3165-3170.

Pitsavos, C., Panagiotakos, D.B., Chrysohoou, C., Kavouras, S. and Stefanadis, C. (2005) The associations between physical activity, inflammation, and coagulation markers, in people with metabolic syndrome: the ATTICA study. European Journal of Cardiovascular Prevention and Rehabilitation 12, 151-158.

Rice, B., Janssen, I., Hudson, R. and Ross, R. (1999) Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men. Diabetes Care 22, 684-691.

Rongvaux, A., Shea, R.J., Mulks, M.H., Gigot, D., Urbain, J., Leo, O. and Andris, F. (2002) Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. European Journal of Immunology 32, 3225-3234.

Ross, R., Dagnone, D., Jones, P.J., Smith, H., Paddags, A., Hudson, R. and Janssen, I. (2000) Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, controlled trial. Annals of Internal Medicine 133, 92-103.

Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S. and McNiece, I. (1994) Cloning and characterization of cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology 14, 1431-1437.

Seo, D.I., Jun, T.W., Park, K.S., Chang, H.K., So, W.Y. and Song, W. (2010) 12weeks combined exercise training is better than aerobic exercise for increasing Growth Hormone in middle-aged women. International Journal of Sport Nutrition and Exercise Metabolism 20, 21-26.

Strasser, B. and Schobersberger, W. (2010) Evidence for Resistance Training as a Treatment Therapy in Obesity. Journal of Obesity 2011, 1-9. Article ID 482564. Available from URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931407/pdf/JOBES2011-482564.pdf

Varma, V., Yao-Borengasser, A., Rasouli, N., Bodles, A.M., Phanavanh, B., Lee, M.J., Starks, T., Kern, L.M., Spencer III, H.J., McGehee, Jr. R.E., Fied, S.K. and Kern, P.A. (2007) Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipid and inflammation. Journal of Clinical Endocrinology and Metabolism 992, 666-672.

Wilson, P.W., D'Agostino, R.B., Parise, H., Sullivan, L. and Meigs, J.B. (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112, 3066-3072.